Peptide questions · NAD+

NAD+ side effects: what studies and users report

Reviewed Evidence: EmergingPublished by PepVault

The side effects most commonly reported for NAD+ are flushing, nausea if dosed too fast and injection site stinging, among 4 the library lists; the library’s evidence on it includes controlled trials in people.

The library holds no separate safety note for NAD+.

What is commonly reported with NAD+

  • Flushing
  • Nausea if dosed too fast
  • Injection site stinging
  • Transient chest tightness (fast IV)

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other longevity compounds the library lists it for
EffectAlso listed for (of 18)
Flushing1: NMN
Nausea if dosed too fastNone: listed for NAD+ alone
Injection site stinging1: Glutathione
Transient chest tightness (fast IV)None: listed for NAD+ alone
A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Track NAD+ in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which NAD+ side effects the longevity group shares

Across the 19 longevity compounds in the library, the effects listed most often are injection site reaction (5 of 19), injection-site discomfort (3 of 19), injection-site redness or itch (3 of 19) and mild headache (3 of 19). NAD+ shares 2 of its 4 listed effects with at least one other longevity compound; nausea if dosed too fast and transient chest tightness (fast IV) are listed for NAD+ alone.

Where the NAD+ reports come from

The library rates the evidence on NAD+ as emerging: mostly preclinical, with limited human data.

Of the library’s 5 research notes on NAD+, 2 rest on clinical data and 3 on community reports.

Our 7 study pages on NAD+: 7 randomized trials.

So NAD+ has controlled trials in people to set its listed effects against.

What our NAD+ study pages report on safety

NMN raised serum nicotinamide over 12 weeks in middle-aged adults

Randomized trial, human, 2023: The 250 mg/day intake was well tolerated, with no adverse events. In healthy middle-aged adults, 12 weeks of NMN raised one NAD+-related blood marker without side effects, but it did not significantly change arterial stiffness.

NMN (MIB-626) raised blood NAD levels in older adults over 14 days

Randomized trial, human, 2023: NAD-related compounds were higher on days 8 and 14 than at baseline, very little unchanged NMN showed up in urine, and side effects were about as common as on placebo. This was a small, 14-day trial in overweight or obese adults aged 55-80, so it does not show long-term safety or how other groups respond.

NAD+ rose with nicotinamide riboside in a 6-week crossover trial

Randomized trial, human, 2018: People tolerated NR well across the 6-week supplementation period. This trial shows that ongoing use of an NAD+ precursor raised NAD+ metabolism in healthy middle-aged and older adults and was well tolerated for 6 weeks.

Questions people ask

What are the side effects of NAD+?

The side effects most commonly reported for NAD+ are flushing, nausea if dosed too fast and injection site stinging, among 4 the library lists; the library’s evidence on it includes controlled trials in people.

Do NAD+’s side effects come from human studies?

The library rates the evidence on NAD+ as emerging, and the library’s evidence on it includes controlled trials in people.

Which NAD+ side effects are its own?

Among the longevity compounds, the library lists nausea if dosed too fast and transient chest tightness (fast IV) for NAD+ alone.

More on NAD+

Track it in the app

PepVault for iPhone

Track NAD+ in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo